Publikationen der ABCSG (peer reviewed) 2021

2021

A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort

P.Dubsky, L.Van’t Veer, M.Gnant, M.Rudas, Z.Bago-Horvath, R.Greil, E.Lujinovic, J.Buresch, G.Rinnerthaler, W.Hulla, F.Moinfar, D.Egle, W.Herz, C.Dreezen, S.Frantal, M.Filipits

ESMO Open, Feb 2021

https://doi.org/10.1016/j.esmoop.2020.100006


Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Erica L Mayer, Amylou C Dueck, Miguel Martin, Gabor Rubovszky, Harold J Burstein, Meritxell Bellet-Ezquerra, Kathy D Miller, Nicholas Zdenkowski, Eric P Winer, Georg Pfeiler, Matthew Goetz, Manuel Ruiz-Borrego, Daniel Anderson, Zbigniew Nowecki, Sibylle Loibl, Stacy Moulder, Alistair Ring, Florian Fitzal, Tiffany Traina, Arlene Chan, Hope S Rugo, Julie Lemieux, Fernando Henao, Alan Lyss, Silvia Antolin Novoa, Antonio C Wolff, Marcus Vetter, Daniel Egle, Patrick G Morris, Eleftherios P Mamounas, Miguel J Gil-Gil, Aleix Prat, Hannes Fohler, Otto Metzger Filho, Magdalena Schwarz, Carter DuFrane, Debora Fumagalli, Kathy Puyana Theall, Dongrui Ray Lu, Cynthia Huang Bartlett, Maria Koehler, Christian Fesl, Angela DeMichele, Michael Gnant,

The Lancet Oncology, Jan 2021,

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30642-2/fulltext